Factors associated with impaired quality of life three months after being diagnosed with COVID-19.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
May 2022
Historique:
accepted: 10 09 2021
pubmed: 29 9 2021
medline: 26 4 2022
entrez: 28 9 2021
Statut: ppublish

Résumé

To assess patient characteristics associated with health-related quality of life (HR-QoL) and its mental and physical subcategories 3 months after diagnosis with COVID-19. In this prospective multicentre cohort study, HR-QoL was assessed in 90 patients using the SF-36 questionnaire (36-item Short Form Health Survey), which consists of 8 health domains that can be divided into a mental and physical health component. Mental health symptoms including anxiety, depression, and post-traumatic stress disorders were evaluated using the Hospital Anxiety and Depression Scale (HADS) and Post-traumatic Stress Disorder Checklist-5 (PCL-5) 3 months after COVID-19. Using descriptive statistics and multivariable regression analysis, we identified factors associated with impaired HR-QoL 3 months after COVID-19 diagnosis. Patients were 55 years of age (IQR, 49-63; 39% women) and were classified as severe (23%), moderate (57%), or mild (20%) according to acute disease severity. HR-QoL was impaired in 28/90 patients (31%). Younger age [per year, adjOR (95%CI) 0.94 (0.88-1.00), p = 0.049], longer hospitalization [per day, adjOR (95%CI) 1.07 (1.01-1.13), p = 0.015], impaired sleep [adjOR (95%CI) 5.54 (1.2-25.61), p = 0.028], and anxiety [adjOR (95%CI) 15.67 (3.03-80.99), p = 0.001) were independently associated with impaired HR-QoL. Twenty-nine percent (n = 26) scored below the normal range on the mental health component of the SF-36 and independent associations emerged for anxiety, depression, and self-reported numbness. Impairments in the physical health component of the SF-36 were reported by 12 (13%) patients and linked to hypogeusia and fatigue. Every third patient reported a reduction in HR-QoL 3 months after COVID-19 diagnosis and impairments were more prominent in mental than physical well-being.

Identifiants

pubmed: 34580823
doi: 10.1007/s11136-021-02998-9
pii: 10.1007/s11136-021-02998-9
pmc: PMC8476326
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1401-1414

Informations de copyright

© 2021. The Author(s).

Références

J Psychosom Res. 2020 Sep;136:110186
pubmed: 32682159
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Front Psychiatry. 2020 Jul 08;11:668
pubmed: 32733299
J Gen Intern Med. 2021 May;36(5):1292-1301
pubmed: 33686587
Front Aging Neurosci. 2021 Jul 19;13:690383
pubmed: 34349633
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
Cell. 2020 May 14;181(4):954-954.e1
pubmed: 32413300
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
J Clin Nurs. 2021 Jun;30(11-12):1742-1750
pubmed: 33656210
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Sci Rep. 2017 Dec 8;7(1):17275
pubmed: 29222500
Br J Gen Pract. 2009 Sep;59(566):e283-8
pubmed: 19761655
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
PLoS One. 2013;8(3):e60477
pubmed: 23555979
BMC Med Res Methodol. 2006 Jan 24;6:2
pubmed: 16433905
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Front Med (Lausanne). 2021 Mar 26;8:578959
pubmed: 33842492
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9
pubmed: 11124729
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
Psychiatry Clin Neurosci. 2020 Sep;74(9):505-506
pubmed: 32609413
Thorax. 2005 May;60(5):401-9
pubmed: 15860716
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
BMC Geriatr. 2021 Mar 22;21(1):199
pubmed: 33752614
Chest. 2021 Jul;160(1):157-164
pubmed: 33640377
Behav Res Ther. 1996 Aug;34(8):669-73
pubmed: 8870294
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Influenza Other Respir Viruses. 2018 Sep;12(5):643-648
pubmed: 29676537
Int J Clin Health Psychol. 2021 Jan-Apr;21(1):100196
pubmed: 32904715
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
PLoS One. 2020 Nov 11;15(11):e0242129
pubmed: 33175906
Chest. 2021 Jul;160(1):187-198
pubmed: 33676998
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
Eur J Neurol. 2021 Oct;28(10):3348-3359
pubmed: 33682276
Curr Rheumatol Rep. 2017 Jan;19(1):1
pubmed: 28116577
Sleep Med. 2021 Apr;80:92-95
pubmed: 33588262
Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198
pubmed: 33448756
Front Psychiatry. 2021 Mar 30;12:625973
pubmed: 33859579
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33303539

Auteurs

Verena Rass (V)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. verena.rass@tirol-kliniken.at.

Bogdan-Andrei Ianosi (BA)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Laura Zamarian (L)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Ronny Beer (R)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Sabina Sahanic (S)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Anna Lindner (A)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Mario Kofler (M)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Alois Josef Schiefecker (AJ)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Philipp Mahlknecht (P)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Beatrice Heim (B)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Victoria Limmert (V)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Thomas Sonnweber (T)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Alex Pizzini (A)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Piotr Tymoszuk (P)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Christoph Scherfler (C)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Atbin Djamshidian (A)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Stefan Kiechl (S)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Ivan Tancevski (I)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Klaus Seppi (K)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Bettina Pfausler (B)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Judith Loeffler-Ragg (J)

Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Raimund Helbok (R)

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH